AMANDA WHITTEN: Open Payments
NPI 1568248474 · GERMANTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$786 in 49 payments from 11 companies in 2025. Trend: 2023 $660 · 2024 $698 · 2025 $786
Food & beverage: $786
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $229 |
| ABBVIE INC. | 10 | $154 |
| Novo Nordisk Inc | 5 | $84 |
| SHIELD THERAPEUTICS INC | 4 | $69 |
| GlaxoSmithKline, LLC. | 4 | $65 |
| Phathom Pharmaceuticals, Inc. | 6 | $63 |
| PFIZER INC. | 3 | $53 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| Dexcom, Inc. | 1 | $16 |
Products named: FARXIGA, LINZESS, ACCRUFER, TRELEGY ELLIPTA, VOQUEZNA, NURTEC ODT, Ozempic, UBRELVY.
Industry payments across TN — which companies pay providers there.
